A L Schafer1, N Napoli, L Lui, A V Schwartz, D M Black. 1. Department of Medicine, University of California, San Francisco, CA, USA; Endocrine Research Unit, Veterans Affairs Medical Center, San Francisco, CA, USA.
Abstract
AIMS: To investigate whether 25-hydroxyvitamin D concentration was associated with incident diabetes in a large cohort of older women. METHODS: Data were analysed from women included in the Study of Osteoporotic Fractures, a cohort of community-dwelling women aged ≥65 years at enrolment. Serum 25-hydroxyvitamin D concentration was assessed at the year 6 visit, as were BMI and other factors associated with vitamin D and/or diabetes. Diabetes status was determined at each subsequent visit by self-report and medication use. Only those without prevalent diabetes at the year 6 visit were included in the present analysis (N = 5463, mean age 76.5 years). RESULTS: During a mean ±sd follow-up of 8.6 ± 4.4 years, incident diabetes was reported in 320 participants. The mean BMI was higher in those with a 25-hydroxyvitamin D concentration <20 ng/ml (<50 nmol/l) than in those with concentrations 20-30 or ≥30 ng/ml [50-74 or ≥75 nmol/l (P < 0.0001)]. A higher 25-hydroxyvitamin D concentration was associated with a 13% lower risk of incident diabetes after adjustment for age and clinic site [hazard ratio 0.87, 95% CI 0.76-0.99, per sd increase in 25-hydroxyvitamin D]; however, the addition of BMI to the model attenuated the estimated effect (hazard ratio 0.97, 95% CI 0.86-1.11). Adjustment for additional potential confounders yielded similar results. CONCLUSIONS: Serum 25-hydroxyvitamin D does not independently predict incident diabetes in older women. Although those with higher 25-hydroxyvitamin D concentrations are less likely to develop diabetes, this is mainly explained by their lower BMI.
AIMS: To investigate whether 25-hydroxyvitamin D concentration was associated with incident diabetes in a large cohort of older women. METHODS: Data were analysed from women included in the Study of Osteoporotic Fractures, a cohort of community-dwelling women aged ≥65 years at enrolment. Serum 25-hydroxyvitamin D concentration was assessed at the year 6 visit, as were BMI and other factors associated with vitamin D and/or diabetes. Diabetes status was determined at each subsequent visit by self-report and medication use. Only those without prevalent diabetes at the year 6 visit were included in the present analysis (N = 5463, mean age 76.5 years). RESULTS: During a mean ±sd follow-up of 8.6 ± 4.4 years, incident diabetes was reported in 320 participants. The mean BMI was higher in those with a 25-hydroxyvitamin D concentration <20 ng/ml (<50 nmol/l) than in those with concentrations 20-30 or ≥30 ng/ml [50-74 or ≥75 nmol/l (P < 0.0001)]. A higher 25-hydroxyvitamin D concentration was associated with a 13% lower risk of incident diabetes after adjustment for age and clinic site [hazard ratio 0.87, 95% CI 0.76-0.99, per sd increase in 25-hydroxyvitamin D]; however, the addition of BMI to the model attenuated the estimated effect (hazard ratio 0.97, 95% CI 0.86-1.11). Adjustment for additional potential confounders yielded similar results. CONCLUSIONS: Serum 25-hydroxyvitamin D does not independently predict incident diabetes in older women. Although those with higher 25-hydroxyvitamin D concentrations are less likely to develop diabetes, this is mainly explained by their lower BMI.
Authors: S R Cummings; D M Black; M C Nevitt; W S Browner; J A Cauley; H K Genant; S R Mascioli; J C Scott; D G Seeley; P Steiger Journal: JAMA Date: 1990-02-02 Impact factor: 56.272
Authors: Anastassios G Pittas; Bess Dawson-Hughes; Tricia Li; Rob M Van Dam; Walter C Willett; Joann E Manson; Frank B Hu Journal: Diabetes Care Date: 2006-03 Impact factor: 19.112
Authors: Ian H de Boer; Lesley F Tinker; Stephanie Connelly; J David Curb; Barbara V Howard; Bryan Kestenbaum; Joseph C Larson; JoAnn E Manson; Karen L Margolis; David S Siscovick; Noel S Weiss Journal: Diabetes Care Date: 2008-01-30 Impact factor: 19.112
Authors: Nicola Napoli; Anne L Schafer; Li-Yung Lui; Jane A Cauley; Elsa S Strotmeyer; Erin S Le Blanc; Andrew R Hoffman; Christine G Lee; Dennis M Black; Ann V Schwartz Journal: Bone Date: 2016-07-05 Impact factor: 4.398
Authors: William B Grant; Sunil J Wimalawansa; Michael F Holick; John J Cannell; Pawel Pludowski; Joan M Lappe; Mary Pittaway; Philip May Journal: Nutrients Date: 2015-02-27 Impact factor: 5.717
Authors: Daniel Mauss; Marc N Jarczok; Kristina Hoffmann; G Neil Thomas; Joachim E Fischer Journal: Int J Med Sci Date: 2015-05-01 Impact factor: 3.738